MOFgen Ltd

United Kingdom
Dunfermline, Scotland, United Kingdom, KY16 9ST

Company profile

MOFgen Ltd company profile

MOFgen Ltd is an award winning VC-backed SME spin-out from the University of St Andrews and is the first company to commercialise MOFs for medical and therapeutic applications. The company’s patented technology was pioneered in the laboratories of world renowned porous material scientist Prof Russell Morris FRS within the School of Chemistry at St Andrews. With roots in the leading research group of its field, MOFgen is exploiting its strong IP and knowhow assets in the areas of MOF design, application, manufacturing and formulation to deliver cutting edge solutions to healthcare challenges. Through an ethos of innovation and collaboration, MOFgen works closely with its partners, to develop bespoke solutions to prevent healthcare associated infections, avoid bacterial resistance, heal chronic wounds and address arterial access.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Founded
2013-01-01, Year

Headquarters

Postal code
KY16 9ST
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$380,323
Last funding
Seed / $380,323 / 2016-12-12
Last equity funding
Seed / $380,323
Investors
2
Closed on
2020-11-28

Founders and investors

Investors

Mercia Fund ManagersScottish Investment Bank